Findings

What do systematic reviews say?

8 questions · 8 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 12.5%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 37.5%Moderate 4 · 50%High 0 · 0%

Sclerotherapy vs placebo

Pain ( · people with telangiectasias and reticular veins

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

Sclerotherapy (STS) vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

Sclerotherapy (STS) showed no clear difference in pain ( compared with sclerotherapy (any sclerosant) (moderate certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 1.49 [0.99, 2.25]
4 studies · 409 participants
Moderate

Laser plus sclerotherapy vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

Laser plus sclerotherapy may leads to higher pain ( compared with sclerotherapy (low certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 2.44 [1.69, 3.55]
1 study · 596 participants
Low

Sclerotherapy (polidocanol) vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 480 participants
Moderate

Sclerotherapy plus compression vs sclerotherapy (any sclerosant)

Pain · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sclerotherapy (hypertonic saline) vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 348 participants
Moderate

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

Sclerotherapy (chromated glycerin) showed no clear difference in pain ( compared with sclerotherapy (any sclerosant) (low certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 1.5 [0.3, 7.55]
1 study · 26 participants
Low

Sclerotherapy (hypertonic glucose plus polidocanol) vs sclerotherapy (hypertonic glucose)

Pain ( · people with telangiectasias and reticular veins

Sclerotherapy (hypertonic glucose plus polidocanol) showed no clear difference in pain ( compared with sclerotherapy (hypertonic glucose) (moderate certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 1.02 [0.83, 1.24]
2 studies · 191 participants
Moderate